March 19th 2024
"I am still struggling with disposing the scopes after each use, both from the environmental aspect and the fact that the scope technically can be used more than once," writes Gopal H. Badlani, MD.
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies
View More
Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Pediatric UTI marker, post-surgery antimicrobial prophylaxis among infection studies to watch for
April 17th 2014In discussing research at the 2014 AUA annual meeting, Anthony J. Schaeffer, MD, called attention to an important paper concerning urinary tract infection in children, as well as another study showing that antimicrobial prophylaxis after surgery is subject to considerable variation.
Stone research indicates URS over ESWL trend continuing
April 17th 2014At the 2012 AUA annual meeting, researchers reported that ureteroscopy had overtaken extracorporeal shock wave lithotripsy (ESWL) as the treatment of choice for kidney stones. Look for research at the 2014 meeting showing that trend is ongoing.
Ophthalmologists update advisory on alpha-blockers
April 14th 2014The American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology have jointly issued an educational update about cataract surgery complications associated with systemic alpha-blockers based on the recent publication of two studies.
Liposomal botulinum shows promise for refractory OAB
April 11th 2014Intravesical administration of a liquid liposomal formulation of onabotulinumtoxinA (“Liposomal BoNT-A,” Lipella Pharmaceuticals) shows promise as a safe and effective treatment for refractory overactive bladder (OAB), according to a pilot study presented at the European Association of Urology annual congress in Stockholm, Sweden.
AUA Exhibit Hall Highlights: Orlando 2014
April 2nd 2014This guide features products and services from manufacturers that are exhibiting at the AUA annual meeting in Orlando. Exhibit hall booth numbers have been included so that you can search for product demonstrations and exhibits that are of particular interest to you.
PVP laser enabling BPH treatment for more patients
March 25th 2014Laser photoselective vaporization prostatectomy is permitting surgical intervention for BPH in a widening array of patients, many of whom harbor comorbidities that would ordinarily exclude them from invasive procedures, according to a new multinational report.
CMS issues two codes for BPH implant procedure
March 20th 2014The Centers for Medicare & Medicaid Services has issued two new codes that describe the UroLift implant procedure for the treatment of enlarged prostate in the April 2014 Update of the Hospital Outpatient Prospective Payment System (OPPS).
Prolapse, SUI treatments found largely equivalent
March 17th 2014For women undergoing surgery for vaginal prolapse and stress urinary incontinence, neither sacrospinous ligament fixation nor uterosacral ligament vaginal vault suspension was superior to the other for functional or adverse event outcomes, according to a recent study.
Physical activity may reduce women’s stone risk
December 18th 2013Postmenopausal women may reduce their risk of incident kidney stone disease by engaging in even mild physical activity and avoiding excessive caloric intake, analyses of data collected in the Women’s Health Initiative (WHI) Observational Study show.
High HgbA1c levels, caloric intake boost stone risk
December 18th 2013Two separate studies provide insight into a pair of factors-diabetes and changes in the American diet-that may boost the risk of kidney stone formation, including the formation of certain stone subtypes. A third study, meanwhile, suggests that medical professionals who work in operating rooms face a higher risk of stones, possibly because of high stress and low fluid intake.
Urinary tract infection agent yields positive phase III study results
December 2nd 2013Ceftolozane/tazobactam, an investigational antibiotic, showed positive top-line results in a pivotal phase III clinical trial of the drug’s use in complicated urinary tract infections, Cubist Pharmaceuticals, Inc. reported.
New Urology Products and Services November 2013
October 29th 2013The latest products and services from SuperSonic Imagine, Auxilium Pharmaceuticals, VIVUS, the Centers for Medicare & Medicaid Services, Innovus Pharmaceuticals, Buffalo Filter, KRS Global Biotechnology, Demos Health, and Ethicon Endo-Surgery.